OpenURL Connection Search

Select item for more details and to access through your institution.

Germline transcription from T-cell receptor Vβ gene is uncoupled from allelic exclusion.
Published in:
EMBO Journal, 2007, v. 26, n. 9, p. 2387, doi. 10.1038/sj.emboj.7601671
By:
- Jia, Jingquan;
- Kondo, Motonari;
- Zhuang, Yuan
Publication type:
Article
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Published in:
Cancer Medicine, 2023, v. 12, n. 19, p. 19394, doi. 10.1002/cam4.6532
By:
- Moore, Elle C.;
- Blobe, Gerard C.;
- DeVito, Nicholas C.;
- Hanks, Brent A.;
- Harrison, Michael R.;
- Hoimes, Christopher J.;
- Jia, Jingquan;
- Morse, Michael A.;
- Jayaprakasan, Parvathy;
- MacKelfresh, Andrew;
- Mulder, Hillary;
- Hockenberry, Adam J.;
- Zander, Alia;
- Stumpe, Martin C.;
- Michuda, Jackson;
- Beauchamp, Kyle A.;
- Perakslis, Eric;
- Taxter, Timothy;
- George, Daniel J.
Publication type:
Article
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Published in:
Cancer Medicine, 2016, v. 5, n. 9, p. 2249, doi. 10.1002/cam4.806
By:
- Hatch, Ace J.;
- Sibley, Alexander B.;
- Starr, Mark D.;
- Brady, J. Chris;
- Jiang, Chen;
- Jia, Jingquan;
- Bowers, Daniel L.;
- Pang, Herbert;
- Owzar, Kouros;
- Niedzwiecki, Donna;
- Innocenti, Federico;
- Venook, Alan P.;
- Hurwitz, Herbert I.;
- Nixon, Andrew B.
Publication type:
Article
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.
Published in:
2022
By:
- Jia, Jingquan;
- Howard, Lauren;
- Liu, Yingmiao;
- Starr, Mark D.;
- Brady, John C.;
- Niedzwiecki, Donna;
- Strickler, John H.;
- Nixon, Andrew B.
Publication type:
journal article
A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors.
Published in:
2019
By:
- Mettu, Niharika B.;
- Niedzwiecki, Donna;
- Rushing, Christel;
- Nixon, Andrew B.;
- Jia, Jingquan;
- Haley, Sherri;
- Honeycutt, Wanda;
- Hurwitz, Herbert;
- Bendell, Johanna C.;
- Uronis, Hope
Publication type:
journal article
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 343, doi. 10.1007/s00280-014-2647-x
By:
- Uronis, Hope;
- Jia, Jingquan;
- Bendell, Johanna;
- Howard, Leigh;
- Ready, Neal;
- Lee, Paula;
- Starr, Mark;
- Dellinger, Andrew;
- Pang, Herbert;
- Nixon, Andrew;
- Hurwitz, Herbert
Publication type:
Article
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 251, doi. 10.1007/s00280-012-1911-1
By:
- Strickler, John;
- Starodub, Alexander;
- Jia, Jingquan;
- Meadows, Kellen;
- Nixon, Andrew;
- Dellinger, Andrew;
- Morse, Michael;
- Uronis, Hope;
- Marcom, P.;
- Zafar, S.;
- Haley, Sherri;
- Hurwitz, Herbert
Publication type:
Article
Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.
Published in:
Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00305
By:
- Jia, Jingquan;
- Morse, Michael A.;
- Nagy, Rebecca J.;
- Lanman, Richard B.;
- Strickler, John H.
Publication type:
Article
Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer.
Published in:
Oncologist, 2021, v. 26, n. 6, p. 465, doi. 10.1002/onco.13678
By:
- Strickler, John H.;
- Rushing, Christel N.;
- Uronis, Hope E.;
- Morse, Michael A.;
- Niedzwiecki, Donna;
- Blobe, Gerard C.;
- Moyer, Ashley N.;
- Bolch, Emily;
- Webb, Renee;
- Haley, Sherri;
- Hatch, Ace J.;
- Altomare, Ivy P.;
- Sherrill, Gary B.;
- Chang, David Z.;
- Wells, James L.;
- Hsu, S. David;
- Jia, Jingquan;
- Zafar, S. Yousuf;
- Nixon, Andrew B.;
- Hurwitz, Herbert I.
Publication type:
Article
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Published in:
Oncologist, 2018, v. 23, n. 7, p. 782, doi. 10.1634/theoncologist.2016-0377
By:
- Vlahovic, Gordana;
- Meadows, Kellen L.;
- Hatch, Ace J.;
- Jia, Jingquan;
- Nixon, Andrew B.;
- Uronis, Hope E.;
- Morse, Michael A.;
- Selim, M. Angelica;
- Crawford, Jeffrey;
- Riedel, Richard F.;
- Zafar, S. Yousuf;
- Howard, Leigh A.;
- O'Neill, Margot;
- Meadows, Jennifer J.;
- Haley, Sherri T.;
- Arrowood, Christy C.;
- Rushing, Christel;
- Pang, Herbert;
- Hurwitz, Herbert I.
Publication type:
Article
E proteins are required to activate germline transcription of the TCR Vβ8.2 gene.
Published in:
European Journal of Immunology, 2008, v. 38, n. 10, p. 2806, doi. 10.1002/eji.200838144
By:
- Jia, Jingquan;
- Dai, Meifang;
- Zhuang, Yuan
Publication type:
Article

Found: 11